Kelsey E Larson

Dr. Kelsey E Larson

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2020 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
PSPriyanka Sharma
Priyanka Sharma
BKBruce F. Kimler
Bruce F. Kimler
AOAnne O'Dea
Anne O'Dea
LNLauren Nye
Lauren Nye
YWYen Y. Wang
Yen Y. Wang
QKQamar Khan
Qamar Khan
Purpose: Addition of carboplatin (Cb) to anthracycline chemotherapy improves pathologic complete response (pCR), and carboplatin plus taxane regimens also yield encouraging pCR rates in triple-negative breast cancer (TNBC). Aim of the NeoSTOP multisite randomized phase II trial was to assess efficacy of anthracycline-free and anthracycline-containing neoadjuvant carboplatin regimens. Patients and Methods: Patients aged ≥18 years with stage I–III TNBC were randomized (1:1) to receive either paclitaxel (P) weekly × 12 plus carboplatin AUC6 every 21 days × 4 followed by doxorubicin/cyclophosphamide (AC) every 14 days × 4 (CbP → AC, arm A), or carboplatin AUC6 + docetaxel (D) every 21 days × 6 (CbD, arm B). Stromal tumor-infiltrating lymphocytes (sTIL) were assessed. Primary endpoint was pCR in breast and axilla. Other endpoints included residual cancer burden (RCB), toxicity, cost, and event-free (EFS) and overall survival (OS). Results: One hundred patients were randomized; arm A (n = 48) or arm B (n = 52). pCR was 54% [95% confidence interval (CI), 40%–69%] in arm A and 54% (95% CI, 40%–68%) in arm B. RCB 0+I rate was 67% in both arms. Median sTIL density was numerically higher in those with pCR compared with those with residual disease (20% vs. 5%; P = 0.25). At median follow-up of 38 months, EFS and OS were similar in the two arms. Grade 3/4 adverse events were more common in arm A compared with arm B, with the most notable differences in neutropenia (60% vs. 8%; P < 0.001) and febrile neutropenia (19% vs. 0%; P < 0.001). There was one treatment-related death (arm A) due to acute leukemia. Mean treatment cost was lower for arm B compared with arm A (P = 0.02). Conclusions: The two-drug CbD regimen yielded pCR, RCB 0+I, and survival rates similar to the four-drug regimen of CbP → AC, but with a more favorable toxicity profile and lower treatment-associated cost.

3 January 2021 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
KSKatelyn Schumacher
Katelyn Schumacher
MIMarc Inciardi
Marc Inciardi
MOMaura O’nEil
Maura O’nEil
JWJamie L. Wagner
Jamie L. Wagner
ISIshani Shah
Ishani Shah
KLKelsey E Larson
Kelsey E Larson

11 July 2023 in The American Journal of Surgery
Verified
Journal Article
Closed access
MCMarisa Carman
Marisa Carman
HZHolly Zink
Holly Zink
KLKelsey E Larson
Kelsey E Larson
CBChrista Balanoff
Christa Balanoff
JWJamie Wagner
Jamie Wagner
Lyndsey KilgoreLyndsey Kilgore
Lyndsey Kilgore

27 February 2023 in Healthcare
Verified
Journal Article
Open access
PDF file
CWChloe Wilder
Chloe Wilder
Lyndsey KilgoreLyndsey Kilgore
Lyndsey Kilgore
AFAbbey Fritzel
Abbey Fritzel
KLKelsey E Larson
Kelsey E Larson
Background: The anatomy curriculum has undergone considerable reductions in class time, resulting in decreased student anatomical knowledge retention and confidence during their surgical rotations. To counter this deficit in anatomy knowledge, a clinical anatomy mentorship program (CAMP) was developed by fourth-year medical student leaders and staff mentors in a near-peer teaching fashion prior to the surgical clerkship. This study analyzed the impact this program had on third-year medical students (MS3s) self-assessed anatomical knowledge and confidence in the operating room on the Breast Surgical Oncology rotation after this near-peer program. Methods: A single-center prospective survey study was performed at an academic medical center. Pre- and post-program surveys were administered to all students who participated in the CAMP and rotated on the breast surgical oncology (BSO) service during the surgery clerkship rotation. A control group of individuals who did not rotate on the CAMP was established, and this group was administered a retrospective survey. A 5-point Likert scale was used to assess surgical anatomy knowledge, confidence in the operating room, and comfort in assisting in the operating room. Control group versus post-CAMP intervention group and pre- versus post-CAMP intervention groups survey results were compared using the Student’s t-test with a p-value of <0.05 statistically significant. Results: All CAMP students rated their surgical anatomy knowledge (p < 0.01), confidence in the operating room (p < 0.01), and comfort in assisting in the operating room (p < 0.01) as greater than those who did not participate in the program. Additionally, the program improved the ability of third-year medical students to prepare for operating room cases going into their third-year breast surgical oncology clerkship (p < 0.03). Conclusions: This near-peer surgical education model appears to be an effective way to prepare third-year medical students for the breast surgical oncology rotation during the surgery clerkship by improving anatomic knowledge and student confidence. The program can serve as a template for medical students, surgical clerkship directors, and other faculty interested in efficiently expanding surgical anatomy at their institution.

23 April 2018 in The Breast Journal
Verified
Journal Article
Closed access
PDF file
KLKelsey E Larson
Kelsey E Larson
SGStephen R Grobmyer
Stephen R Grobmyer
SVStephanie A Valente
Stephanie A Valente

5 October 2023 in The American Journal of Surgery
Verified
Journal Article
Open access
CHCorey Hounschell
Corey Hounschell
Lyndsey KilgoreLyndsey Kilgore
Lyndsey Kilgore
PPPeggy Pruitt
Peggy Pruitt
CWChloe Wilder
Chloe Wilder
CBChrista R. Balanoff
Christa R. Balanoff
KLKelsey E Larson
Kelsey E Larson
Indocyanine green (IcG) is an alternative to isosulfan blue (IB) for sentinel lymph node (SLN) mapping in breast cancer (BC). IcG carries improved cost and safety, but oncologic data upon implementation in practice is limited. We evaluated the learning curve defined as oncologic yield and operative (OR) time for IcG in SLN mapping in BC. Retrospective review of patients >18 years with cTis-2 cN0 BC undergoing surgery first with SLN biopsy using IB or IcG. Analysis compared IB versus IcG across three time cohorts. Of 278 patients, 77 received IB and 201 received IcG. OR time was longer for IcG (p ​= ​0.022). There was no difference in oncologic yield between groups (p ​= ​0.35, p ​= ​0.61). Surgeons may be able to safely transition from IB to IcG for patients with early-stage breast cancer undergoing surgery first. Individuals should track their own data to confirm safety of the technique.